The Japan unit of US pharmaceutical giant Johnson & Johnson and a Tokyo-based firm selling medical products were searched by the country’s antitrust watchdog over potential violations of the antimonopoly law, sources close to the matter said Tuesday.
The Japan Fair Trade Commission suspects Johnson & Johnson K.K. and ASP Japan of obstructing competitors’ sales of cleaners and disinfectants for endoscopes.
Related: Pfizer, Johnson & Johnson Settle High-Profile Remicade Antitrust Suit
ASP Japan said on its website that it was formerly under Johnson & Johnson until 2019 and specializes in infection prevention technology.
According to the sources, the companies allegedly required that only their disinfectants be used in endoscope cleaners that their trading partners produce. They are also believed to have created equipment maintenance contracts with hospitals that stipulate using their disinfectants.
The commission said it is looking into possible obstruction of trading and forced buying of tie-in products. Japan’s antimonopoly law bans both practices.
Featured News
FTC to Approve Exxon’s $64 Billion Deal with Pioneer Resources, Excludes
May 1, 2024 by
CPI
UK Competition Watchdog Raises Alarm Over Nvidia’s ARM Takeover
May 1, 2024 by
CPI
Sen. Klobuchar Urges Regulators to Probe Collusion in Health Care Pricing
May 1, 2024 by
CPI
Multiple States Join Tennessee’s Antitrust Lawsuit Against NCAA Over NIL Rules
May 1, 2024 by
CPI
NY AG Joins Suit Challenging NCAA’s Restrictions on Student Athlete NIL Rights
May 1, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI